Ketamine Infusion for Comorbid PTSD and Chronic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

June 4, 2019

Study Completion Date

June 4, 2019

Conditions
PTSDChronic Pain
Interventions
DRUG

A single low dose ketamine infusion as compared to the IV infusion of active placebo - ketorolac on chronic pain and PTSD symptoms.

Subjects were randomized into 4 treatment groups: chronic pain subjects treated with ketorolac, chronic pain subjects treated with ketamine, chronic pain+PTSD subjects treated with ketorolac, and chronic pain+PTSD subjects treated with ketamine.

Trial Locations (1)

48105

Ann Arbor VA Medical Center, Ann Arbor

All Listed Sponsors
collaborator

University of Michigan

OTHER

lead

VA Ann Arbor Healthcare System

FED

NCT04322968 - Ketamine Infusion for Comorbid PTSD and Chronic Pain | Biotech Hunter | Biotech Hunter